»
Antibodies
»
anti-Mitogen-Activated Protein Kinase Kinase 1/2 (MAP2K1/2) (pSer218,pSer222) anti...
Mitogen-Activated Protein Kinase Kinase 1/2 (MAP2K1/2) (pSer218,pSer222) antibody
| Antigen |
|
|
Epitope
|
|
| Clonality |
Polyclonal |
|
Host
|
|
|
Reactivity
|
|
|
Application
|
|
| Catalog no. |
ABIN238350 |
| Quantity |
0.05 mg (1.0 mg/ml) |
| Price |
265.00 $ Plus shipping costs $35.00
|
| Shipping to |
|
| Availability |
Ships within 7 to 10 Business Days |
|
Characteristics
|
Synonyms: MEK1, MEK2, MKK2, MKK1, PRKMK1, PRKMK2
|
|
Alternative name
|
MAPKK1 / MAPKK 2
|
|
Immunogen
|
Synthetic peptide (coupled with KLH) derived from aminoacid sequence 33-53 of humanMAPK Kinase 1. Remarks: The immunogen sequence is highly conserved within species (human, mouse,rat, hamster, bovine etc. ).
|
|
Cross-Reactivity
|
Human
|
|
Description
|
MEK (MAPKK, kinase of mitogen-activated protein kinase) is the medium one of threecomponents of MAP kinase cascade - an important signaling pathway that regulates cellgrowth and differentiation. Raf (MAPKKK) activates MEK 1 and 2 via phosphorylation of twoserine residues (Ser218 and Ser222). Activated MEK 1/2 then acts as a dual specificitykinase phosphorylating both a threonine and a tyrosine residue on ERK (MAPK,mitogen-activated protein kinase). This phosphorylation of ERK by MEK 1/2 is a critical stepin the MAP kinase cascade. Phosphorylated ERK is capable of translocating to the nucleus,where it regulates gene expression by activating transcription factors.
|
|
Specificity
|
The polyclonal antibody reacts with MEK 1/2. MEK 1 and MEK 2 are integral components ofthe MAP kinase cascade, an important pathway for cell growth and differentiation. Species: Human. Others not tested.
|
|
Application Notes
|
Western Blotting under reducing and non-reducing conditions: Recommended dilution: 0.5 μg/mlPositive material: RAJI human Burkitt lymphoma cell lineSample preparation: Resuspend approx.50 mil. cells in 1 ml cold Lysis buffer (1%laurylmaltoside in 20 mM Tris/Cl, 100 mM NaCl pH 8.2, 50 mM NaF including Proteaseinhibitor Cocktail). Incubate 60 min on ice. Centrifuge to remove cell debris. Mix lysatewith non-reducing/reducing Laemmli SDS-PAGE sample buffer. Boil for 5 min. Reducing conditions are recommended. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
|
|
Concentration
|
1.0 mg/ml
|
|
Purification
|
Purified
|
|
Buffer
|
PBS containing 15 mM sodium azide as preservative and 0.2% (w/v)high-grade BSA (Protease free) as stabilizer.
|
|
Storage
|
Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch
|
|
Restrictions
|
For Research Use only
|
Alternatives for antigen "Mitogen-Activated Protein Kinase Kinase 1/2 (MAP2K1/2)", type "Antibodies"
|
Hosts
|
Rabbit (19), Mouse (1)
|
|
Reactivities
|
Human (20), Rat (Rattus) (16), Mouse (Murine) (14), Dog (Canine) (1), Mammalian (1), Xenopus laevis (1)
|
|
Applications
|
Western Blotting (WB) (18), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (6), Immunohistochemistry (IHC) (4), ELISA (3), Enzyme Immunoassay (EIA) (2), Immunofluorescence (IF) (2)
|
|
Epitopes
|
pSer217/221 (2), Ab-221 (1), pSer217 (1), pSer218/222 (1), pSer221 (1)
|